GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...

Comparatively, obesity rates in most European countries remain below 25 percent, with some nations, particularly in Southern ...

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

The researchers suggest that sleep deprivation may exacerbate the inflammatory state associated with obesity by increasing ...

Prime Minister Narendra Modi in his Mann Ki Baat broadcast highlighted the critical issue of obesity, citing WHO data that ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses ...

Lilly recently revised its revenue forecast for 2024 after seeing weaker-than-expected growth for Zepbound and diabetes brand ...

Legislatures, governors, government agencies, and plaintiff attorneys are taking action against ultra-processed foods, but ...

Attendees engaged in insightful discussions, expert-led presentations, and interactive case studies, gaining valuable ...

Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...

Obesity trends have stayed stable in the last couple years, whereas severe obesity has trended downward, a recently published report suggested.However, the percentage of people with a healthy weight ...

Researchers from the Max Planck Institute for Metabolism Research in Germany have discovered that what we call the "dessert ...